Healthcare -
Medical - Diagnostics & Research - NASDAQ - US
$ 12.39
-1.04 %
$ 1.13 B
Market Cap
-9.68
P/E
MYGN - REVENUE
Revenue MYGN - Myriad Genetics, Inc.
753 M
LAST VALUE
4.43%
2 YEAR CAGR
-2.41%
5 YEAR CAGR
-0.33%
10 YEAR CAGR